Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07452211Not ApplicableCompleted

First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient

Role: lead

NCT07036965Not ApplicableRecruiting

Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation

Role: lead

NCT06157437Not ApplicableRecruiting

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia

Role: lead

NCT05731882Not ApplicableUnknown

First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder

Role: lead

NCT05911685Not ApplicableUnknown

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Role: lead

NCT05360771Not ApplicableNot Yet Recruiting

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

Role: lead

NCT05114954Not ApplicableCompleted

Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)

Role: lead

All 7 trials loaded